Stifel Nicolaus Initiates Coverage on National Health Investors (NHI) with a Buy
More News related to NHI
- National Health (NHI) Declares $0.55 Quarterly Dividend; 7.3% Yield
- National Health Investors Inc. (NHI) Reports Q3 Normalized-FFO of $0.71, Tops Analyst Estimate
- NHI Announces Fourth Quarter Dividend
- NHI Reports Third Quarter Normalized FFO of $0.61
- Hilliard Lyons Initiates Coverage on National Health Investors (NHI) with a Long-Term Buy
Stifel Nicolaus initiates coverage on National Health Investors (NYSE: NHI) with a Buy. Price target $29.
To see more analyst ratings on NHI Click Here.
National Health Investors, Inc. (NHI) is a real estate investment trust (REIT), which invests in health care properties primarily in the long-term care industry.
Related Categories
New CoverageStocks Mentioned
+0.14Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
